Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

Guillermo Garcia‐Manero, Gail J. Roboz, Jesús G. Berdeja et al.|Cancer|2017

Cited by 106